Literature DB >> 2495247

Control by IFN-gamma and PGE2 of TNF alpha and IL-1 production by human monocytes.

P H Hart1, G A Whitty, D S Piccoli, J A Hamilton.   

Abstract

There have been suggestions that the production of pro-inflammatory mediators by human monocytes in response to interferon-gamma (IFN-gamma) may be controlled by changes in prostaglandins. Therefore we investigated tumour necrosis factor alpha (TNF alpha) and interleukin-1 (IL-1) activities and prostaglandin E2 (PGE2) levels in the supernatants of highly purified human monocytes cultured for 18 hr with recombinant human IFN-gamma. IFN-gamma (100 U/ml) did not stimulate monocytes isolated by counter-current centrifugal elutriation for detectable TNF alpha or IL-1 activities, or PGE2 production. However, IFN-gamma synergistically enhanced lipopolysaccharide (LPS)-induced TNF alpha and IL-1 activities. In contrast, there was no consistent change in PGE2 levels upon addition of IFN-gamma to LPS-treated monocyte cultures. The TNF alpha and IL-1 activities induced by LPS and by LPS with IFN-gamma were reduced by PGE2, and stimulated by indomethacin. As reported previously for IL-1 activities, the regulation by cyclo-oxygenase products of TNF alpha activities reflected predominantly a control of the production of immunoreactive TNF alpha, rather than the measurement of TNF alpha bio-activity. However, the addition of indomethacin or PGE2 to monocyte cultures did not change the extent of IFN-gamma synergy with LPS for increased TNF alpha and IL-1 activities. The results of this study suggest that, despite control by cyclo-oxygenase products of TNF alpha and IL-1 production in human monocytes, IFN-gamma may enhance TNF alpha and IL-1 activities independently of this regulatory mechanism. These findings are contrary to those suggested for the regulation by prostanoids of IL-1 production by murine macrophages.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2495247      PMCID: PMC1385223     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  30 in total

1.  Effect of interferon on the induction of human monocyte secretion of interleukin-1 activity.

Authors:  R C Newton
Journal:  Immunology       Date:  1985-11       Impact factor: 7.397

2.  Prostaglandins as endogenous mediators of interleukin 1 production.

Authors:  S L Kunkel; S W Chensue; S H Phan
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

3.  Prostaglandins posttranscriptionally inhibit monocyte expression of interleukin 1 activity by increasing intracellular cyclic adenosine monophosphate.

Authors:  P J Knudsen; C A Dinarello; T B Strom
Journal:  J Immunol       Date:  1986-11-15       Impact factor: 5.422

4.  Interferon-gamma enhances expression of cellular receptors for tumor necrosis factor.

Authors:  M Tsujimoto; Y K Yip; J Vilcek
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

5.  Human monocyte heterogeneity: interleukin 1 and prostaglandin E2 production by separate subsets.

Authors:  N Khansari; Y K Chou; H H Fudenberg
Journal:  Eur J Immunol       Date:  1985-01       Impact factor: 5.532

6.  Interferon-gamma modulates protein kinase C activity in murine peritoneal macrophages.

Authors:  T A Hamilton; D L Becton; S D Somers; P W Gray; D O Adams
Journal:  J Biol Chem       Date:  1985-02-10       Impact factor: 5.157

7.  Effect of interleukin 2, interferon-gamma, and mitogens on the production of tumor necrosis factors alpha and beta.

Authors:  G E Nedwin; L P Svedersky; T S Bringman; M A Palladino; D V Goeddel
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

8.  Regulation of macrophage tumor necrosis factor production by prostaglandin E2.

Authors:  S L Kunkel; R C Wiggins; S W Chensue; J Larrick
Journal:  Biochem Biophys Res Commun       Date:  1986-05-29       Impact factor: 3.575

9.  Concurrent enhancement of monocyte immunoregulatory properties and effector functions by recombinant interferon-gamma.

Authors:  D J Tweardy; H Fujiwara; J J Scillian; J J Ellner
Journal:  Cell Immunol       Date:  1986-06       Impact factor: 4.868

10.  Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.

Authors:  C A Dinarello; J G Cannon; S M Wolff; H A Bernheim; B Beutler; A Cerami; I S Figari; M A Palladino; J V O'Connor
Journal:  J Exp Med       Date:  1986-06-01       Impact factor: 14.307

View more
  41 in total

1.  Monocyte zinc and in vitro prostaglandin E2 and interleukin-1 beta production by cultured peripheral blood monocytes in patients with Crohn's disease.

Authors:  H F Goode; B J Rathbone; J Kelleher; B E Walker
Journal:  Dig Dis Sci       Date:  1991-05       Impact factor: 3.199

2.  Human immunoglobulin preparation for intravenous use induces elevation of cellular cyclic adenosine 3':5'-monophosphate levels, resulting in suppression of tumour necrosis factor alpha and interleukin-1 production.

Authors:  T Shimozato; M Iwata; H Kawada; N Tamura
Journal:  Immunology       Date:  1991-04       Impact factor: 7.397

3.  Modulatory effect of prostaglandins on human monocyte activation for killing of high- and low-virulence strains of Paracoccidioides brasiliensis.

Authors:  A M Soares; S A Calvi; M T Peraçoli; A C Fernandez; L A Dias; A R Dos Anjos
Journal:  Immunology       Date:  2001-04       Impact factor: 7.397

4.  Differential effects of LPS, IFN-gamma and TNF alpha on the secretion of lysozyme by individual human mononuclear phagocytes: relationship to cell maturity.

Authors:  C E Lewis; S P McCarthy; J Lorenzen; J O McGee
Journal:  Immunology       Date:  1990-03       Impact factor: 7.397

Review 5.  Cytokines and eicosanoids in rheumatic diseases.

Authors:  S J Hopkins
Journal:  Ann Rheum Dis       Date:  1990-04       Impact factor: 19.103

6.  Prostaglandin E2 Inhibits NLRP3 Inflammasome Activation through EP4 Receptor and Intracellular Cyclic AMP in Human Macrophages.

Authors:  Milena Sokolowska; Li-Yuan Chen; Yueqin Liu; Asuncion Martinez-Anton; Hai-Yan Qi; Carolea Logun; Sara Alsaaty; Yong Hwan Park; Daniel L Kastner; Jae Jin Chae; James H Shelhamer
Journal:  J Immunol       Date:  2015-04-27       Impact factor: 5.422

7.  Interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) are necessary in the early stages of induction of CD4 and CD8 cytotoxic T cells by Mycobacterium leprae heat shock protein (hsp) 65 kD.

Authors:  M C Sasiain; S de la Barrera; S Fink; M Finiasz; M Alemán; M H Fariña; G Pizzariello; R Valdez
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

8.  The modulatory effects of prostaglandin-E on cytokine production by human peripheral blood mononuclear cells are independent of the prostaglandin subtype.

Authors:  Maaike M B W Dooper; Lianne Wassink; Laura M'Rabet; Yvo M F Graus
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

Review 9.  Inhibition of prostaglandin E2 formation and histamine action in cancer immunotherapy.

Authors:  P Uotila
Journal:  Cancer Immunol Immunother       Date:  1993-09       Impact factor: 6.968

10.  Interleukin-4 suppresses granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in stimulated human monocytes.

Authors:  J A Hamilton; G A Whitty; A K Royston; J Cebon; J E Layton
Journal:  Immunology       Date:  1992-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.